Alprostadil associated with low molecular weight heparin to treat limb ischemia caused by SARS-CoV2

Abstract The current coronavirus pandemic has already taken a great toll globally, causing massive morbidity and mortality. One of its severe forms is a thrombophilic state that can damage several systems. This article reports the case of 60-year-old female patient who presented with mild flu symptoms, which turned out to be a SARS-CoV2 infection, and ended up developing arterial thrombosis with limb ischemia in a private care hospital in Sorocaba, São Paulo, Brazil. Considering this progression, we decided to intervene with low molecular weight heparin and Alprostadil, achieving a good clinical outcome. Our description aims to identify key points and clinical signs that offer evidence of the therapeutic window and a treatment option for coagulatory presentations of COVID-19.

Bibliographic Details

Main Authors:	Manhanelli Filho,Marcos Antonio Bonacorso, Duarte Júnior,Eliud Garcia, Mariuba,Jamil Victor de Oliveira, Linardi,Fábio, Costa,José Augusto, Gali,Julio Cesar, Yoshida,Winston Bonetti, Gali Filho,Julio Cesar
Format:	Digital revista
Language:	English
Published:	Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2020
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-54492020000100623
Tags:	Add Tag No Tags, Be the first to tag this record!